Bilateral Optic Neuropathy in a Patient with Imatinib Usage

Raziye Dönmez Gün, A. Koçkar, B. Altunrende, E. Şengül
{"title":"Bilateral Optic Neuropathy in a Patient with Imatinib Usage","authors":"Raziye Dönmez Gün, A. Koçkar, B. Altunrende, E. Şengül","doi":"10.5336/caserep.2019-70978","DOIUrl":null,"url":null,"abstract":"ABS TRACT A 59-year-old woman presented with a painless vision loss in her left eye for five days. The nasal side of the right optic nerve head was mildly oedematous and hyperaemic, and the left optic nerve head was oedematous and hyperaemic. She was diagnosed as bilateral optic neuropathy. Imatinib was stopped, intravenous metilprednisolone was given for a week. The vision and fundus findings recovered in a few days. After 2 months imatinib was restarted, there was no ocular side effects until now. Imatinib is an important drug in the treatment of chronic myeloid leukemia, but bilateral optic neuropathy, which is a serious ocular side effect, may be seen related to imatinib mesylate usage.","PeriodicalId":23460,"journal":{"name":"Türkiye Klinikleri Journal of Case Reports","volume":"5 1","pages":"9-12"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Türkiye Klinikleri Journal of Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5336/caserep.2019-70978","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ABS TRACT A 59-year-old woman presented with a painless vision loss in her left eye for five days. The nasal side of the right optic nerve head was mildly oedematous and hyperaemic, and the left optic nerve head was oedematous and hyperaemic. She was diagnosed as bilateral optic neuropathy. Imatinib was stopped, intravenous metilprednisolone was given for a week. The vision and fundus findings recovered in a few days. After 2 months imatinib was restarted, there was no ocular side effects until now. Imatinib is an important drug in the treatment of chronic myeloid leukemia, but bilateral optic neuropathy, which is a serious ocular side effect, may be seen related to imatinib mesylate usage.
使用伊马替尼患者的双侧视神经病变
一名59岁女性,左眼无痛性视力丧失5天。右侧视神经头鼻部轻度水肿充血,左侧视神经头轻度水肿充血。她被诊断为双侧视神经病变。停用伊马替尼,静脉注射甲泼尼龙一周。几天后视力和眼底恢复。重新使用伊马替尼2个月后,至今无眼部副作用。伊马替尼是治疗慢性髓系白血病的重要药物,但甲磺酸伊马替尼的使用可能与双侧视神经病变有关,而视神经病变是严重的眼部副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信